We are live on ! Find out more
NI

Nextech Invest Portfolio holdings

AUM $1.42B
1-Year Est. Return 304.47%
This Fund
S&P 500
This Quarter Est. Return
+5.45%
1 Year Est. Return
+304.47%
3 Year Est. Return
+631.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$310M
AUM Growth
+$13.2M
Cap. Flow
+$961K
Cap. Flow %
0.31%
Top 10 Hldgs %
92.96%
Holding
14
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$5.49M

Top Sells

Rank Stock Value
1
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$4.53M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$38.5B
$82.6M 26.68%
4,189,529
+250,000
+6% +$5.49M
EQRX
2
DELISTED
EQRx, Inc. Common Stock
EQRX
$64.9M 20.95%
13,104,424
– –
KNTE
3
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$31.8M 10.27%
2,661,888
-346,355
-12% -$4.53M
TYRA icon
4
Tyra Biosciences
TYRA
$1.85B
$22.1M 7.15%
2,518,582
– –
MRTX
5
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$18.4M 5.95%
263,914
– –
PMVP icon
6
PMV Pharmaceuticals
PMVP
$57.1M
$16.5M 5.33%
1,385,807
– –
CGEM icon
7
Cullinan Oncology
CGEM
$1.06B
$15.7M 5.06%
1,221,145
– –
ARVN icon
8
Arvinas
ARVN
$530M
$12.8M 4.13%
287,251
– –
BPMC
9
DELISTED
Blueprint Medicines
BPMC
$12.4M 4.01%
188,228
– –
RLAY icon
10
Relay Therapeutics
RLAY
$4B
$10.6M 3.44%
475,485
– –
SPRY icon
11
ARS Pharmaceuticals
SPRY
$579M
$10.1M 3.26%
1,910,029
– –
KRON
12
DELISTED
Kronos Bio
KRON
$4.86M 1.57%
1,451,537
– –
THRX
13
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$3.55M 1.15%
611,310
– –
CCCC icon
14
C4 Therapeutics
CCCC
$389M
$3.3M 1.06%
375,857
– –

Similar funds

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return
KCMH
Kontiki Capital Management (HK) Hong Kong $1.43B AUM 9.81% 1-Year Est. Return
APCM
Alaska Permanent Capital Management Anchorage, Alaska $1.43B AUM 13.12% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Nextech Invest's Q3 2022 Portfolio in Review

As of Q3 2022, Nextech Invest held 14 positions worth $310M, up 4.4% from $296M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Nextech Invest opened no new positions and made no exits, leaving the 14-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Nextech Invest added most to Revolution Medicines in Q3 2022, an estimated $5.49M increase.
  • Nextech Invest's biggest Q3 2022 reduction was Kinnate Biopharma Inc. Common Stock, cutting an estimated $4.53M.
  • Nextech Invest's ten largest holdings make up 93% of its $310M portfolio in Q3 2022.
  • Nextech Invest opened 0 new positions and closed 0 in Q3 2022.
  • Nextech Invest's portfolio value rose 4.4% quarter-over-quarter to $310M.

Based on Nextech Invest's 13F filing for Q3 2022, filed 14 Nov 2022.